1. Ayd, F. J.: Persistent dyskinesia: a neurologic complication of major tranquilizers. Med. Sci. 18, 32?40 (1967)
2. Barbeau, A.: l-Dopa therapy in Parkinson's disease: A critical review of nine years' experience. Canad. med. Ass. J. 101, 791?800 (1969)
3. Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., Seitelberger, F.: Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. neurol. Sci. 20, 415?455 (1973)
4. Birket-Smith, E.: Abnormal involuntary movements induced by anticholinergic therapy. Acta neurol. scand. 50, 801?811 (1974)
5. Carlsson, A.: Biochemical implications of dopa-induced actions on the central nervous system, with particular reference to abnormal movements. In: l-Dopa and Parkinsonism, A. Barbeau and F. H. McDowell, eds., pp. 205?213. Philadelphia: F. A. Davis 1970